MedTrace Logo

The HVIP+ Community Model

NCT07539142 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2026-06-02

No results posted yet for this study

Summary

The present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.

Conditions

  • Hospital-based Violence Intervention
  • Community Firearm Violence
  • Firearm Behaviors

Interventions

BEHAVIORAL

Brief Bedside

* Initial support (in-hospital or shortly after if discharged early) * Needs assessment * Resource Sheet of Vetted Partners

BEHAVIORAL

Peer Support

* Weekly Check-ins * Status Check (Personal/family; Health; Mental Health; Spiritual, etc.) * Encouragement/Motivation (Staying safe, Doing right, etc.) * In-Person Visits (Home, Rehab, etc.) * Peer Social/Skill-building Activities (Money management, Job interviewing, Computer literacy, Creative arts, Critical thinking film discussions, etc.)

BEHAVIORAL

Case Management + Voucher

* Service Plan \& Referrals * Service Check-in/Follow up with partners and participants * Navigation of Health Care and Social Service Follow up appointments * Transportation Assistance * Basic life skills for service provision (riding bus/public transportation, zoom, etc.) * Vouchers for Immediate Needs/Obstacles

BEHAVIORAL

SELF Group Therapy Sessions

* Virtual Bi-weekly Group Therapy * SELF Curriculum- Trauma Focused Cognitive Behavioral Therapy * Lead by Therapists and Community Peer Volunteers * One-on-one Introductory/Intake Orientations

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Nakita Lovelady, PhD, MPH · University of Arkansas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07539142 on ClinicalTrials.gov